{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchangeTimezoneName": "Australia/Sydney", "exchangeTimezoneShortName": "AEST", "currency": "AUD", "market": "au_market", "esgPopulated": false, "gmtOffSetMilliseconds": 36000000, "exchange": "ASX", "longName": "Starpharma Holdings Limited", "shortName": "STARPHARMA FPO", "regularMarketPrice": 0.455, "regularMarketChangePercent": 3.4090943, "messageBoardId": "finmb_4493458", "marketState": "POSTPOST", "fiftyTwoWeekHighChangePercent": -0.46470588, "fiftyTwoWeekLow": 0.43, "fiftyTwoWeekHigh": 0.85, "earningsTimestamp": 1682638290, "earningsTimestampStart": 1682638290, "earningsTimestampEnd": 1682638290, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "fiftyTwoWeekLowChange": 0.025000006, "fiftyTwoWeekLowChangePercent": 0.058139548, "fiftyTwoWeekRange": "0.43 - 0.85", "fiftyTwoWeekHighChange": -0.395, "epsTrailingTwelveMonths": -0.04, "epsForward": -0.02, "sharesOutstanding": 410492992, "bookValue": 0.1, "fiftyDayAverage": 0.4833, "fiftyDayAverageChange": -0.028299987, "fiftyDayAverageChangePercent": -0.058555737, "twoHundredDayAverage": 0.569975, "twoHundredDayAverageChange": -0.114975005, "twoHundredDayAverageChangePercent": -0.20171937, "marketCap": 186774320, "forwardPE": -22.750002, "priceToBook": 4.55, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 970095600000, "priceHint": 4, "regularMarketChange": 0.0150000155, "regularMarketTime": 1683870983, "regularMarketDayHigh": 0.46, "regularMarketDayRange": "0.44 - 0.46", "regularMarketDayLow": 0.44, "regularMarketVolume": 125858, "regularMarketPreviousClose": 0.44, "bid": 0.45, "ask": 0.455, "bidSize": 0, "askSize": 0, "fullExchangeName": "ASX", "financialCurrency": "AUD", "regularMarketOpen": 0.44, "averageDailyVolume3Month": 118364, "averageDailyVolume10Day": 57545, "symbol": "SPL.AX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "4-6 Southampton Crescent", "city": "Abbotsford", "state": "VIC", "zip": "3067", "country": "Australia", "phone": "61 3 8532 2700", "fax": "61 3 9510 5955", "website": "https://starpharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. It offers VivaGel, a non-antibiotic therapy for the treatment and prevention of bacterial vaginosis. The company also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, it develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase 2 clinical trials, DEP cabazitaxel that is in Phase 2 clinical trial, DEP gemcitabine that is in a Phase 1/2 clinical trials, and DEP irinotecan that is in Phase 2 clinical trials for the treatment of cancer; DEP radiotheranostics for cancer treatment and diagnosis; DEP Antibody Drug Conjugates; DEP HER-2 ADC; DEP non-oncology candidates; and DEP AZD0466, which is in Phase 1/2 clinical trials to treat haematological malignancies. The company was founded in 1996 and is headquartered in Abbotsford, Australia.", "fullTimeEmployees": 50, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jacinth K. Fairley B.Sc., B.V.Sc.(Hons), GAICD, MBA", "age": 59, "title": "CEO, MD & Exec. Director", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": {"raw": 774614, "fmt": "774.61k", "longFmt": "774,614"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Justin  Cahill", "title": "CFO & Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Tracy  Weimar BA, MBA", "title": "Joint Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 5, "boardRisk": 2, "compensationRisk": 7, "shareHolderRightsRisk": 1, "overallRisk": 2, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}